- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00877344
Better Contraceptive Choices: Immediate or Delayed Insertion of IUC After Second Trimester Abortion
Better Contraceptive Choices: Immediate vs. Delayed Insertion of Intrauterine Contraception After Second Trimester Abortion
Hypothesis
Intrauterine contraception placed immediately after a second trimester abortion will result in fewer pregnancies than current standard practice of intended placement at 4 weeks post-abortion.
Study Design
Randomized Controlled Trial after their second trimester abortion comparing immediate with delayed insertion of IUC, and a non intervention control group choosing non-intrauterine contraception. Participants choosing an IUC will be randomly assigned to immediate or delayed insertion. The investigators primary outcome is pregnancy rate within one year.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Actual)
Phase
- Phase 4
Contacts and Locations
Study Locations
-
-
British Columbia
-
Kelowna, British Columbia, Canada
- Kelowna General Hospital Women's Services Clinic
-
Vancouver, British Columbia, Canada
- BC Women's Hospital
-
Vancouver, British Columbia, Canada
- Elizabeth Bagshaw Women's Clinic
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Have completed informed consent for an abortion at gestation between 12 weeks zero days and 23 weeks 6 days, and
- Choosing an IUC (either LNG-IUC or CuT380-IUC) for contraception post abortion, and
- Residents of British Columbia, registered with the Medical Services Plan health care system.
Exclusion Criteria:
- Intention to move from BC within the next year
- Intention to conceive within the next year.
- Any of the following contraindications to use of a LNG-IUC or a CuT380-IUC
- Post Randomization Exclusion:
uterine perforation at the time of abortion
bleeding of more than 500 cc during abortion
any of the above exclusions detected at time of abortion
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: 1
Immediate insertion of either a LNG-IUC or a Copper T380 IUD after 12-24 week abortion
|
Immediate timing of insertion for a LNG-IUC OR Copper 380mg T-shaped IUD after an abortion for a gestational age between 12 weeks zero days and 23 weeks 6 days.
Immediate insertions occur during the visit for the abortion immediately after the abortion is complete, interval insertions will be scheduled for not earlier than two weeks and not later than four weeks after the abortion.
|
Experimental: 2
Interval insertion (two to four weeks post abortion) of either a LNG-IUC or a Copper T380 IUD after 12-24 abortion
|
Interval Timing of insertion for a LNG-IUC OR Copper 380mg T-shaped IUD after an abortion for a gestational age between 12 weeks zero days and 23 weeks 6 days.
Immediate insertions occur during the visit for the abortion immediately after the abortion is complete, interval insertions will be scheduled for not earlier than two weeks and not later than four weeks after the abortion.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Pregnancy rate at one year
Time Frame: 12 months
|
The one year pregnancy rate outcome will be determined using a pragmatic approximation based on the varying exactitude of imputations based on provincial Medical Service Plan billings related to abortions, miscarriages, still births and live births.
Subsequent abortions performed within our study clinics for enrolled participants will be noted along with specific clinical information on pregnancy duration.
For abortions performed elsewhere such as those for BC university students studying out of province, or those performed by individual physicians at rural or remote hospitals within BC, exact gestation may not be available.
In the BC health administrative databases abortions are billed as under 7 weeks for medical abortions, and as under 14 weeks, 14 weeks to under 18 weeks, and 18 weeks and over for surgical abortions.
Miscarriages by definition occur anytime under 20 weeks or are classed as still birth when over 20 weeks of gestation.
|
12 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Rates at one year for Expulsion, Continuation of use, Satisfaction with method, Adverse events.
Time Frame: 60 months
|
Secondary outcomes will be assessed initially at one year, then annually through the five year device effectiveness period.
|
60 months
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Wendy V. Norman, Ph.D, University of British Columbia
- Study Director: Brian Fitzsimmons, MD, University of British Columbia
- Study Chair: Lyda Dicus, University of British Columbia
Study record dates
Study Major Dates
Study Start
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- H09-00363
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pregnancy
-
Far Eastern Memorial HospitalCompletedCornual PregnancyTaiwan
-
Peking Union Medical College HospitalPeking Union Medical CollegeUnknownPregnancy | Pregnancy Related | Infant | Pregnancy Disease | Risk FactorChina
-
Centre Hospitalier Universitaire de Saint EtienneCompletedProlonged PregnancyFrance
-
University Hospital, ToursCompleted
-
Ufuk UniversityNot yet recruitingPregnancy Complications | Pregnancy Loss | Pregnancy Preterm
-
Hadassah Medical OrganizationCompleted
-
Technische Universität DresdenWithdrawnPregnancy Trimester, Second | Pregnancy Trimester, First | Pregnancy Trimester, ThirdGermany
-
Universitair Ziekenhuis BrusselMerck Serono International SAUnknownPregnancy | Pregnancy LossBelgium
-
Turku University HospitalUniversity of TurkuCompleted
-
Centre Hospitalier René DubosCompletedDeciduitis; Complicating Pregnancy
Clinical Trials on Immediate insertion
-
Karolinska InstitutetRecruitingContraceptive UsageSweden
-
Planned Parenthood League of MassachusettsBrigham and Women's Hospital; Society of Family Planning; Mulago Hospital, UgandaCompleted
-
Ain Shams Maternity HospitalCompletedContraception | IUDEgypt
-
Oregon Health and Science UniversityCompleted
-
Riina KorjamoCompletedContraception After Medical AbortionFinland
-
University of New MexicoSociety of Family PlanningCompletedContraceptionUnited States
-
Legacy Health SystemDevers Eye Institute; Lions Eye Bank of Oregon Vision Research Laboratory; Fischer...UnknownFuchs' Corneal Endothelial DystrophyUnited States
-
Samsung Medical CenterCompletedTumor Appearance of Biliary System ObstructionKorea, Republic of
-
Ajou University School of MedicineRecruitingObesity | Arrhythmias, Cardiac | Implantable Defibrillator User | Cardiovascular MorbidityKorea, Republic of
-
Holland Bloorview Kids Rehabilitation HospitalActive, not recruitingCerebral Palsy | Chronic PainCanada